1-U 1 f1u_050219.htm FORM 1-U

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 1-U

CURRENT REPORT PURSUANT REGULATION A

Date of Report (Date of earliest event reported) May 2, 2019

 

 

True Leaf Medicine International Ltd.
(Exact name of registrant as specified in its charter)
     
British Columbia   000-00000
State or other jurisdiction of incorporation or organization   (I.R.S. Employer 
    Identification No.)
     
100 Kalamalka Lake Road, Unit 32, Vernon, British Columbia V1T 9G1
(Full mailing address of principal executive offices)
     
778-389-9933
Issuer's telephone number, including area code
     
Title of each class of securities issued pursuant to Regulation A: Common Shares

 

 
 

 

Item 9.    Other Events

 

Press Release

 

On May 2, 2019, True Leaf Medicine International Ltd. (the "Issuer") issued a release to announce that True Leaf receives nearly $1 million CAD in proceeds through successful warrant exercise.

 

Item 10.    Exhibits

 

15.1     Press Release dated May 2, 2019

 

 

SIGNATURES

 

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

True Leaf Medicine International Ltd.

 

     
  /s/ Darcy Bomford  
By:    
  Darcy Bomford  
  Chief Executive Officer of True Leaf  

 

 

Date:  May 2, 2019